Growing clinical and experimental evidence suggests the importance of the VWF–ADAMTS‐13 axis not only in hemostasis, bleeding disorders, and TTP, but also in cardiovascular disease. This evidence concerns the gene ADAMTS13 and hemorrhagic disease.